Publication: Clinical Benefit of First-Line Cemiplimab in Patients with Locally Advanced NSCLC: Subgroup Analysis from EMPOWER-Lung 1
No Thumbnail Available
Date
2021-10-01T00:00:00Z
Authors
Authors
GÜMÜŞ, MAHMUT
Sezer, A.
Kilickap, S.
ÖZGÜROĞLU, Mustafa
Gogishvili, M.
Turk, H. M.
Cicin, I.
Bentsion, D.
Gladkov, O.
Clingan, P.
Journal Title
Journal ISSN
Volume Title
Publisher
Metrics
Abstract
Description
Keywords
Citation
Bondarenko I., Sezer A., Kilickap S., GÜMÜŞ M., ÖZGÜROĞLU M., Gogishvili M., Turk H. M. , Cicin I., Bentsion D., Gladkov O., et al., -Clinical Benefit of First-Line Cemiplimab in Patients with Locally Advanced NSCLC: Subgroup Analysis from EMPOWER-Lung 1-, JOURNAL OF THORACIC ONCOLOGY, cilt.16, sa.10, 2021